Two- and three-dimensional QSAR studies on a set of antimycobacterial pyrroles: CoMFA, Topomer CoMFA, and HQSAR

Medicinal Chemistry Research

Volumn 23, Issue 1, 2014, Pages 107-126

  Joshi, Shrinivas D ^a   More, Uttam A ^a,b   Aminabhavi, Tejraj M ^a   Badiger, Aravind M ^c  

^a S E T S COLLEGE OF PHARMACY   (India)

^b PRIST UNIVERSITY   (India)

^c BDR Pharmaceuticals International Pvt Ltd   (India)

Author keywords

Antimycobacterial pyrroles; HQSAR; QSAR: CoMFA; Topomer CoMFA

Indexed keywords

EID: 84893706743     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-013-0607-3     Document Type: Article

References (42)

1. Agarwal A, Taylor EW (1993) 3-D QSAR for intrinsic activity of 5-HT1 A receptor ligands by the method of comparative molecular field analysis. J Comput Chem 14(2):237-245
2. Bakkestuen AK, Gundersen LL, Langli G, Liu F, Nolsøe JM (2000) 9-Benzylpurines with inhibitory activity against Mycobacterium tuberculosis. Bioorg Med Chem Lett 10:1207-1210
3. Baurin N, Vangrevelinghe E, Morin-Allory L, Mérour JY, Renard P, Payard M, Guillaumet G, Marot C (2000) 3D-QSAR CoMFA study on imidazolinergic I2 ligands: a significant model through a combined exploration of structural diversity and methodology. J Med Chem 43:1109-1122
4. Biava M, Fioravanti R, Porretta GC, Deidda D, Maullu C, Pompei R (1999) New pyrrole derivatives as antimycobacterial agents analogs of BM212. Biorg Med Chem Lett 9:2983-2988
5. Biava M, Cesare Porretta G, Deidda D, Pompei R, Tafi A, Manetti F (2003) Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212 Biorg Med Chem 11:515-520
6. Bush BL, Nachbar RB Jr (1993) Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J Comput Aided Mol Des 7:587-619
7. Clark M, Cramer RD III, Jones DM, Patterson DE, Simeroth PE (1990) Comparative molecular field analysis (CoMFA). 2. Toward its use with 3D-structural databases. Tetrahedron Comput Methodol 3(1):47-59
8. Coats EA (1998) The CoMFA steroids as a benchmark dataset for development of 3D QSAR methods. Perspect Drug Discov Des 12(13/14):199-213
9. Cramer RD III (2011) Rethinking 3D-QSAR. J Comput Aided Mol Des 25:197-201
10. Cramer RD III, Reld G, Berkoff CE (1974) Substructural analysis. A novel approach to the problem of drug design. J Med Chem 17:533-535
11. Cramer RD III, Patterson DE, Bunce JD (1988a) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding steroids to carrier proteins. J Am Chem Soc 110:5959-5967
12. Cramer RD III, Bunce JD, Patterson DE, Frank IE (1988b) Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant Struct Act Relat 7:18-25 (erratum 1988, 7:91)
13. Cramer RD III, Patterson DE, Bunce JD (1989) Recent advances in comparative molecular field analysis (CoMFA). Prog Clin Biol Res 291:161-165
14. Cramer RD III, Clark RD, Patterson DE, Ferguson AM (1996) Bioisosterism as a molecular diversity descriptor: steric fields of single "topomeric" conformers. J Med Chem 39(16):3060-3069
15. Dabak K, Sezer O, Akar A, Anac O (2003) Synthesis and investigation of tuberculosis inhibition activities of some 1,2,3-triazole derivatives. Eur J Med Chem 38:215-218
16. Daffe M, Draper P (1998) The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39:131-203. doi: 10.1016/S0065-2911(08)60016-8
17. Dean PM (1993) Molecular similarity. In: Kubunyi H (ed) 3D QSAR in drug design: theory, methods and applications. ESCOM Science Publishers, Leiden, pp 150-172
18. Dolin PJ, Raviglione MC, Kochi A (1994) Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 72:213-220
19. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686. doi: 10.1001/jama.282.7.677
20. Hansch C, Leo A (1995) Exploring QSAR. Fundamentals and applications in chemistry and biology. American Chemical Society, Washington, DC
21. Head RD, Smythe ML, Oprea TI, Waller CL, Green SM, Marshall GR (1996) VALIDATE: a new method for the receptor-based prediction of binding affinities of novel ligands. J Am Chem Soc 118:3959-3969
22. Jackson CJ, Lamb DC, Kelly DE, Kelly SL (2000) Bactericidal and inhibitory effects of azole antifungal compounds on Mycobacterium smegmatis. FEMS Microbiol Lett 192:159-162
23. Jilek RJ, Cramer RD III (2004) Topomers: a validated protocol for their self-consistent generation. J Chem Inf Comp Sci 44:1221-1227
24. Joshi SD, Vagdevi HM, Vaidya VP, Gadaginamath GS (2008) Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems, a novel class of potential antibacterial and antitubercular agents. Eur J Med Chem 43:1989-1996
25. Joshi SD, More Y, Vagdevi HM, Vaidya VP, Gadaginamath GS, Kulkarni VH (2013) Synthesis of new 4-(2,5-dimethylpyrrol-1-yl)/4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyrrole ring systems a novel class of potential antibacterial, antifungal and antitubercular agents. Med Chem Res 22:1073-1089
26. Klimesova V, Zahajska L, Waisser K, Kaustova J, Mollmann U (2004) Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives II. Farmaco 59:279-288
27. Kucukguzel SG, Oruc EE, Rollas S, Sahin F, Ozbek A (2002) Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds. Eur J Med Chem 37:197-206
28. Kuçukguzel I, Kuçukguzel SG, Rollas S, Kiraz M (2001) Some 3-thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials. Biorg Med Chem Lett 11:1703-1707
29. Lemmen C, Lengauer T (2000) Computational methods for the structural alignment of molecules. J Comput Aided Mol Des 14:215-232
30. Lowis DR (1998) HQSAR a new, highly predictive QSAR technique. www.tripos.com/AppNotes/HQSAR/hqsar.html
31. Mamolo MG, Zampieri D, Falagiani V, Vio L, Banfi E (2003) Synthesis and antifungal activity of (±)-1-(5-aryl-3-pyridin-2-yl-4,5-dihydro-pyrazol- 1-yl)-2-imidazol-1-yl-ethanone derivatives. II Farmaco 58:315-322
32. Na YM, Le Borgne M, Pagniez F, Le Baut G, Le Pape P (2003) Synthesis and antifungal activity of new 1-halogenobenzyl-3-imidazolylmethylindole derivatives. Eur J Med Chem 38:75-87
33. Sanna P, Carta A, Nikookar ME (2000) Synthesis and antitubercular activity of 3-aryl substituted-2-[1H(2H)benzotriazol-1(2)-yl]acrylonitriles. Eur J Med Chem 35:535-543
34. Sbardella G, Mai A, Artico M, Loddo R, Setzu MG, La Colla P (2004) Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2- oxazolidinone analogues of PNU-100480. Biorg Med Chem Lett 14:1537-1541
35. Somu RV, Boshoff H, Qiao C, Bennett EM, Barry CE 3rd, Aldrich CC (2006) Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain. J Med Chem 49:31-34
36. Testa B, Carrupt PA, Gaillard P, Tasai RS (1997) Intra molecular interactions encoded in lipophilicity. In: Pliska V, Testa B, Van der Waterbeemd H (eds) Lipophilicity in drug action and toxicology. Wiley, Weinheim, p 49
37. Tirado-Rives J, Jorgensen W (2006) Contribution of conformer focusing on the uncertainty in predicting free energies for protein-ligand binding. J Med Chem 49:5880-5884
38. Tong W, Lowis DR, Perkins R, Chen Y, Welsh WJ, Goddette DW, Hetitage TW, Sheehan DM (1998) Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen descriptor. J Chem Inf Comput Sci 38:669-677
39. Tripos International (2012) Sybyl-X 2.0, Tripos International, St. Louis, MO
40. Ulusoy N, Gursoy A, Otuk G (2001) Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. II Farmaco 56:947-952
41. Warren GL, Andrews CW, Capelli A-M, Clarke B, Lalonde B, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID, Woolven JM, Peishoff CE, Head MS (2006) A critical assessment of docking programs and scoring functions. J Med Chem 49:5912-5931
42. Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z (2003) Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 52:790-795